Korea S.E.
06:00:00 2024-04-24 pm EDT
5-day change
1st Jan Change
519
KRW
+1.17%
+4.01%
-4.77%
SM Fund acquired 0.41% stake stake in UGint Co., Ltd. for approximately KRW 930 million.
SM Fund acquired 0.41% stake in UGint Co., Ltd. (KOSDAQ:A195990) for approximately KRW 930 million on July 27, 2017. SM Fund acquired 1.5 million shares at KRW 617 per share.
SM Fund completed the acquisition of 0.41% stake stake in UGint Co., Ltd. (KOSDAQ:A195990) on July 27, 2017.
Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.
22-12-15
CI
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.
22-09-25
CI
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
21-12-23
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
21-10-13
CI
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
21-06-17
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
21-06-15
CI
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.
20-12-21
CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.
20-12-14
CI
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
20-11-25
CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors
20-11-17
CI
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..
20-10-24
CI
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..
20-10-22
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.
20-10-21
CI
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index
20-09-21
CI
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.
19-12-30
CI
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.
19-11-28
CI
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.
19-11-17
CI
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding
19-11-13
CI
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding
19-10-30
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 14 billion in funding
19-10-28
CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 19.999997712 billion in funding
19-08-26
CI
Ugint CO., Ltd. announced that it has received KRW 14.322 billion in funding
19-08-22
CI
Ugint CO., Ltd. announced that it expects to receive KRW 14.322 billion in funding
19-07-10
CI
Ugint CO., Ltd. announced that it has received KRW 15 billion in funding
19-04-22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.
More about the company
1st Jan change
Capi.
-4.77% 108M +54.30% 3.43B +5.77% 1.99B -7.87% 1.88B -6.48% 1.36B +15.70% 1.36B -17.68% 1.35B -29.98% 1.28B -18.88% 1.22B -0.74% 1.19B
Machine Tools
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
ABPRO BIO CO., LTD. 
